The patch is scheduled to be marketed under the trademark TETRACAN, and will be available at medical marijuana dispensaries by the end of 2011 across the US.
It is the first exclusively controlled and discernible departure from the traditional delivery smoking modality of marijuana.
MMDS plans to develop manufacturing facilities in Europe to distribute TETRACAN globally to jurisdictions which accept TETRACAN as a holistic, therapeutic adjunctive for chronic pain conditions such as arthritis, chemotherapy side effects, and multiple sclerosis.
MMDS is also discussing distribution initiatives for TETRACAN and future associated derivatives in the Medical Marijuana States of California and Colorado with the Medicine Wheel Project.
Patch inventor Walter Cristobal said that working with MMDS will finally bring the Patch and other new delivery systems like creams, gels and oils to people and animals in need of chronic pain management.
The Medicine Wheel Project actively advocates medical marijuana and advancement of a Marijuana Industry-Wide Association.